biologic

Ixinity

Coagulation Factor IX (Recombinant)

Loss of exclusivity—loss of exclusivity

CompanyMedexus Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand name	Ixinity
Active ingredient	Coagulation Factor IX (Recombinant)
Strength	1500IU
Dosage form	For Injection
Route	Intravenous
Modality	Biologic
Marketing status	Rx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.